PLANEGG-MARTINSRIED, Germany--(BUSINESS WIRE)--Ad hoc announcement in accordance with §15 WpHG [Securities Trading Act] 4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced the successful completion of a capital increase, after the Management Board, with the approval of the Supervisory Board, passed a resolution to authorise an increase of share capital on 23 October, 2009. The capital increase from the authorised capital included a collateral rights offering to existing shareholders at a subscription price of EUR3.00 per share. The remaining unsubscribed shares were allocated through a private placement in order to raise in the range of EUR25 to 30 million proceeds. The capital raising was completed at the top of the range and generated EUR30 million gross proceeds. The subscribed shares were not fully allocated.
